- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 14, 2026 | 409.39M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 409.07M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 393.06M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 384.1M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 373.39M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $32.82K |
| Capex | Q3 2026 · Mar 31, 2025 | $1.04M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$113.37K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$4.64M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $6.44M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $7.01M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $4.72M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $5.37M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $5.86M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $6.38M |
| Stockholders Equity restated | Q3 2026 · Sep 30, 2024 | $7.01M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $7.68M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $10.88M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $12.01M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $11.77M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $12.12M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $13M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $12.16M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $18.22M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $17.49M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $738.62K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $2.22M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $614.18K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $2.12M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$572.6K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$1.91M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$683.36K |
| Net Income | Q3 2026 · Sep 30, 2025 | −$651.55K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$573.97K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$2.08M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$813.84K |
| Net Income | Q3 2026 · Sep 30, 2024 | −$694.07K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$561.85K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$1.87M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$547.71K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.99M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $205.05K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $439.88K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $92.81K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $275.45K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $358.39K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $733.39K |
| Revenue | Q3 2026 · Mar 31, 2026 | $563.43K |
| Revenue | Q3 2026 · Mar 31, 2026 | $1.17M |
| Revenue | Q3 2026 · Mar 31, 2025 | $92.81K |
| Revenue | Q3 2026 · Mar 31, 2025 | $275.45K |